Clinical Trial Update: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial assessing the safety and efficacy of ponesimod for moderate-to-severe chronic plaque psoriasis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Ponesimod (ponesimod)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Moderate-to-severe Chronic Plaque Psoriasis | Phase 3 | Status: NOT_YET_RECRUITING